Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Swinney

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Nature Reviews. Drug Discovery|June 25, 2011
How were new medicines discovered?David C Swinney, Jason Anthony
Current Drug Discovery Technologies|January 16, 2016
Enzyme Activity Assays for Protein Kinases: Strategies to Identify Active SubstratesBrad A Haubrich, David C Swinney
F1000Research|August 28, 2020
Recent advances in phenotypic drug discoveryDavid C Swinney, Jonathan A Lee
Trends in Pharmacological Sciences|November 6, 2020
Fluxes for Unraveling Complex Binding MechanismsGeorges Vauquelin, Dominique Maes, David C Swinney
SLAS Discovery : Advancing Life Sciences R & D|October 5, 2019
Development of a Bioluminescent High-Throughput Screening Assay for Nicotinamide Mononucleotide Adenylyltransferase (NMNAT)Brad A Haubrich, Chakk Ramesha, David C Swinney
British Journal of Pharmacology|January 26, 2016
On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targetsGeorges Vauquelin, Isabelle Van Liefde, David C Swinney
Biochemistry|January 29, 2010
Steady-state kinetic characterization of kinase activity and requirements for Mg2+ of interleukin-1 receptor-associated kinase-4Mohammad Hekmat-Nejad, Terrence Cai, David C Swinney
Drug Discovery Today. Technologies|January 3, 2016
Radioligand binding to intact cells as a tool for extended drug screening in a representative physiological contextGeorges Vauquelin, Isabelle Van Liefde, David C Swinney
The Journal of Biological Chemistry|November 17, 2010
Characterization of the elongation complex of dengue virus RNA polymerase: assembly, kinetics of nucleotide incorporation, and fidelityZhinan Jin, Jerome Deval, Kenneth A Johnson, et al.
F1000Research|February 17, 2015
Collaboration for rare disease drug discovery researchNadia K Litterman, Michele Rhee, David C Swinney, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Nature Reviews. Drug Discovery|June 25, 2011
How were new medicines discovered?David C Swinney, Jason Anthony
Current Drug Discovery Technologies|January 16, 2016
Enzyme Activity Assays for Protein Kinases: Strategies to Identify Active SubstratesBrad A Haubrich, David C Swinney
F1000Research|August 28, 2020
Recent advances in phenotypic drug discoveryDavid C Swinney, Jonathan A Lee
Trends in Pharmacological Sciences|November 6, 2020
Fluxes for Unraveling Complex Binding MechanismsGeorges Vauquelin, Dominique Maes, David C Swinney
SLAS Discovery : Advancing Life Sciences R & D|October 5, 2019
Development of a Bioluminescent High-Throughput Screening Assay for Nicotinamide Mononucleotide Adenylyltransferase (NMNAT)Brad A Haubrich, Chakk Ramesha, David C Swinney
British Journal of Pharmacology|January 26, 2016
On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targetsGeorges Vauquelin, Isabelle Van Liefde, David C Swinney
Biochemistry|January 29, 2010
Steady-state kinetic characterization of kinase activity and requirements for Mg2+ of interleukin-1 receptor-associated kinase-4Mohammad Hekmat-Nejad, Terrence Cai, David C Swinney
Drug Discovery Today. Technologies|January 3, 2016
Radioligand binding to intact cells as a tool for extended drug screening in a representative physiological contextGeorges Vauquelin, Isabelle Van Liefde, David C Swinney
The Journal of Biological Chemistry|November 17, 2010
Characterization of the elongation complex of dengue virus RNA polymerase: assembly, kinetics of nucleotide incorporation, and fidelityZhinan Jin, Jerome Deval, Kenneth A Johnson, et al.
F1000Research|February 17, 2015
Collaboration for rare disease drug discovery researchNadia K Litterman, Michele Rhee, David C Swinney, et al.
Pageof 4